April 12, 2021 – Medline Industries Inc. (Northfield, IL) is reportedly exploring a sale that could value the medical-supply giant at as much as $30 billion, according to The Wall Street Journal.
The family-owned company has hired Goldman Sachs Group Inc. to run the process, people familiar with the matter told the WSJ.
Some of the WSJ’s sources said that an IPO or minority investment is also a possibility.
There is no guarantee the company will ultimately be sold and the process is at an early stage.
Blackstone Group Inc., KKR & Co. and Carlyle Group Inc. are among those expected to consider bids, some of the people said, and they could ultimately partner up given the size of the deal.
Medline, which boasts around $17.5 billion in annual sales, manufactures and distributes medical equipment and supplies used in hospitals, surgery centers, acute-care and other medical facilities in over 125 countries.
The company’s products include surgical gowns, examination gloves and diagnostic equipment used in medical settings as well as a few consumer-facing brands such as Curad bandages.